Skip to content
OpenCapital
Get started

Ginkgo Bioworks DNA Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$19.5MMiss by $23.5M
EPS-$1.28Miss by $0.07
Revenue estimate$42.9M
EPS estimate-$1.21

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$24.1M
EPS estimate-$0.90

Financials

Q1 2026

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$486.67M-40.4%
Enterprise value$708.7M-28.7%
P/S3.4×-0.3×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Segments

By segment

See full
Reportable Segment$19.5M—

Versus estimates

Revenue

Q1 2026$19.5MMiss by $23.5M
Q4 2025$33.0MMiss by $4.1MQ3 2025$38.8MBeat by $1.3MQ2 2025$49.6MBeat by $10.7MQ1 2025$48.3MBeat by $6.7MQ4 2024$43.8MBeat by $5.2M

Diluted EPS

Q1 2026-$1.28Miss by $0.07
Q4 2025-$1.42Beat by $0.38Q3 2025-$1.45Miss by $0.21Q2 2025-$1.10Beat by $0.34Q1 2025-$1.58Miss by $0.35Q4 2024-$1.82Miss by $0.37

Ask the moment Ginkgo Bioworks reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Ginkgo Bioworks report Q1 2026 earnings?
Ginkgo Bioworks (DNA) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Ginkgo Bioworks's Q1 2026 revenue and EPS?
Ginkgo Bioworks reported revenue of $19.5M and eps of $-1.28 for Q1 2026.
Did Ginkgo Bioworks beat estimates in Q1 2026?
Revenue missed the consensus estimate of $42.9M by $23.5M. EPS missed the consensus estimate of $-1.21 by $0.07.
How did Ginkgo Bioworks's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 59.7% from $48.3M a year earlier and eps grew 19.0% from $-1.58.
Where can I find Ginkgo Bioworks's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-032093) and the 10-Q periodic report (0001628280-26-032116) directly on SEC EDGAR. The filing index links above go to sec.gov.